Evolving role of Anti-CD20 monoclonal antibodies in rheumatoid arthritis: efficacy, safety, economic perspectives, and future directions—a narrative review
B-cell depletion has established an important therapeutic role in rheumatoid arthritis (RA), particularly in selected patients with an inadequate response to tumor necrosis factor inhibitors or with clinical features favoring rituximab. However, the optimal positioning of anti-CD20 therapy remains constrained by...